FCN3 and systemic lupus erythematosus: From a clinical point of view, these data support the usefulness of anti-ficolin-3 as an additional serological biomarker for the diagnosis of active lupus with renal manifestation, but additional longitudinal studies are needed to validate the diagnostic and/or prognostic role of this new SLE parameter.